<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ca">
	<id>https://rthwiki.iconcologia.net/index.php?action=history&amp;feed=atom&amp;title=IPSS_%28S%C3%ADndromes_mielodispl%C3%A1sicos%29-es</id>
	<title>IPSS (Síndromes mielodisplásicos)-es - Historial de revisió</title>
	<link rel="self" type="application/atom+xml" href="https://rthwiki.iconcologia.net/index.php?action=history&amp;feed=atom&amp;title=IPSS_%28S%C3%ADndromes_mielodispl%C3%A1sicos%29-es"/>
	<link rel="alternate" type="text/html" href="https://rthwiki.iconcologia.net/index.php?title=IPSS_(S%C3%ADndromes_mielodispl%C3%A1sicos)-es&amp;action=history"/>
	<updated>2026-05-14T12:23:47Z</updated>
	<subtitle>Historial de revisió per a aquesta pàgina del wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://rthwiki.iconcologia.net/index.php?title=IPSS_(S%C3%ADndromes_mielodispl%C3%A1sicos)-es&amp;diff=1058&amp;oldid=prev</id>
		<title>Lesteban a 10:00, 23 juny 2022</title>
		<link rel="alternate" type="text/html" href="https://rthwiki.iconcologia.net/index.php?title=IPSS_(S%C3%ADndromes_mielodispl%C3%A1sicos)-es&amp;diff=1058&amp;oldid=prev"/>
		<updated>2022-06-23T10:00:31Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;ca&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Versió més antiga&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revisió del 10:00, 23 juny 2022&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l60&quot;&gt;Línia 60:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Línia 60:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;Referencias bibliográficas&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;Referencias bibliográficas&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;references /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;references /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;[[Categoria:Variables del registro]]&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Lesteban</name></author>
	</entry>
	<entry>
		<id>https://rthwiki.iconcologia.net/index.php?title=IPSS_(S%C3%ADndromes_mielodispl%C3%A1sicos)-es&amp;diff=993&amp;oldid=prev</id>
		<title>Lesteban: IPSS(Síndromes mielodisplásicos)-es</title>
		<link rel="alternate" type="text/html" href="https://rthwiki.iconcologia.net/index.php?title=IPSS_(S%C3%ADndromes_mielodispl%C3%A1sicos)-es&amp;diff=993&amp;oldid=prev"/>
		<updated>2022-06-21T10:54:40Z</updated>

		<summary type="html">&lt;p&gt;IPSS(Síndromes mielodisplásicos)-es&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Pàgina nova&lt;/b&gt;&lt;/p&gt;&lt;div&gt;PSS (&amp;#039;&amp;#039;International Prognostic Scoring System&amp;#039;&amp;#039;) se calcula para todos los síndromes mielodisplásicos (SMD): M9980.3-M9993.3.&amp;lt;ref name=&amp;quot;:0&amp;quot;&amp;gt;International Classification of Diseases for Oncology (ICD-O) - 3rd edition, 2nd revision. http://www.iacr.com.fr/+index.php?option=com_content&amp;amp;view=category&amp;amp;layout=blog&amp;amp;id=100&amp;amp;Itemid=577&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
El IPSS para los SMD se calcula teniendo en cuenta los siguientes parámetros &amp;lt;ref name=&amp;quot;:1&amp;quot;&amp;gt;https://www.lls.org/myelodysplastic-syndromes/diagnosis/international-prognostic-scoring-system&amp;lt;/ref&amp;gt;:&lt;br /&gt;
* % de blastos.&lt;br /&gt;
*Cariotipo: buen pronóstico, intermedio o mal pronóstico.&lt;br /&gt;
*Número de citopenias: 0-1 vs 2-3.&lt;br /&gt;
Las puntuaciones que se atribuyen a cada uno de los parámetros anteriores son &amp;lt;ref name=&amp;quot;:1&amp;quot; /&amp;gt;:&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Puntuación de los parámetros incluidos en el cálculo del IPSS de los SMD.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|&amp;#039;&amp;#039;&amp;#039;% Blastos&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;#039;&amp;#039;&amp;#039;Cariotipo&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;#039;&amp;#039;&amp;#039;Nº Citopenias&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;5% = 0 puntos&lt;br /&gt;
|Buen Pronóstico= 0 puntos&lt;br /&gt;
&amp;lt;nowiki&amp;gt;*&amp;lt;/nowiki&amp;gt;Ninguna alteración cromosómica, del(5q) o del(20q)&lt;br /&gt;
|0-1 citopenias= 0 puntos&lt;br /&gt;
|-&lt;br /&gt;
|5-10 = 0,5 puntos&lt;br /&gt;
|Intermedio= 0,5 puntos&lt;br /&gt;
&amp;lt;nowiki&amp;gt;*&amp;lt;/nowiki&amp;gt;Otras alteraciones cromosómicas&lt;br /&gt;
|2-3 citopenias = 0,5 puntos&lt;br /&gt;
|-&lt;br /&gt;
|11-20 = 1 punto&lt;br /&gt;
|Mal pronóstico= 1 punto&lt;br /&gt;
&amp;lt;nowiki&amp;gt;*&amp;lt;/nowiki&amp;gt;3 alteraciones cromosómicas o más, alteraciones en el cromosoma 7&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|21-30 = 1,5 puntos&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
IPSS se categoriza según se muestra en la siguiente tabla &amp;lt;ref name=&amp;quot;:1&amp;quot; /&amp;gt;:&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Grupos de riesgo de los SMD según IPSS.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|&amp;#039;&amp;#039;&amp;#039;Puntuación&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;#039;&amp;#039;&amp;#039;Riesgo&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|-&lt;br /&gt;
|0&lt;br /&gt;
|Bajo riesgo&lt;br /&gt;
|-&lt;br /&gt;
|0,5-1&lt;br /&gt;
|Riesgo intermedio - 1&lt;br /&gt;
|-&lt;br /&gt;
|1,5-2&lt;br /&gt;
|Riesgo intermedio  -2&lt;br /&gt;
|-&lt;br /&gt;
|&amp;gt;2&lt;br /&gt;
|Alto riesgo&lt;br /&gt;
|}En ASEDAT, se tiene que recoger la variable &amp;quot;IPSS Síndromes mielodisplásicos&amp;quot; para las morfologías M9980.3-M9993.3&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt; y los valores que puede tomar son: 0 (Bajo riesgo), 0.5-1 (Riesgo intermedio -1); 1.5-2(Riesgo intermedio -2); &amp;gt;2 (Alto riesgo).&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Referencias bibliográficas&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Lesteban</name></author>
	</entry>
</feed>